Enzymotec factory in Migdal HaEmek
צילום: אבי פריור
Kibbutz-based Enzymotec Ltd. rings NASDAQ opening bell
Company president, senior execs mark nutritional ingredient company's new market listing in opening trade day ceremony in major stock exchange. Based in kibbutz Ma'anit, Enzymotec's stock leaped 30% since first listing in September
Israeli company Enzymotec's directors had the honor of ringing the NASDAQ Stock Market opening bell in New York, NY, one of the world's largest and most important stock exchanges.
On Wednesday, company president and CEO, Dr. Ariel Katz, along with other senior executives, participated in the bell ringing ceremony to commemorate Enzymotec's listing on the NASDAQ Global Select Market under the symbol "ENZY," Wall Street Journal's Market Watch reported.
(צילום: Zef Nikolla)
In NASDAQ, Wednesday (Photo; Zef Nikolla)
The company has gone public about a month ago, selling over $62 million in shares on its first day on the market.
Since then, the company's stock has gone up a remarkable 30%.
Enzymotec, founded about 15 years ago in kibbutz Ma'anit in central Israel, specializes in developing lipid-based nutritional ingredients which are familiar to human body and designed to uniquely address dietary needs and dietary management for prevention of medical disorders and common diseases.
About 40% of the company's shares are owned by Ma'anit.
Navit Zomer contributed to this report
- Receive Ynetnews updates directly to your desktop
